Welbe Management

Management criteria checks 2/4

Welbe's CEO is Makoto Ota, appointed in Dec 2011, has a tenure of 12.5 years. directly owns 20% of the company’s shares, worth ¥5.98B. The average tenure of the management team and the board of directors is 8 years and 5 years respectively.

Key information

Makoto Ota

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	12.5yrs
CEO ownership	20.0%
Management average tenure	8yrs
Board average tenure	5yrs

Recent management updates

Recent updates

Why Investors Shouldn't Be Surprised By Welbe, Inc.'s (TSE:6556) 28% Share Price Surge

Feb 26

CEO

Makoto Ota (52 yo)

12.5yrs

Tenure

Mr. Makoto Ota serves as President and Representative Director at Welbe, Inc. since December 2011. Mr. Ota served as Director & Vice President; General Manager of Administration Division; Manager of Medica...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Makoto Ota	President & Representative Director	12.5yrs	no data	20% ¥ 6.0b
Hideyuki Nakazato	GM of Welfare Service Business Department & Director	8.6yrs	no data	0% ¥ 0
Takao Senga	Senior EVP	8yrs	no data	0% ¥ 0
Koichi Ito	Director & GM of Business Planning Department	4.2yrs	no data	0% ¥ 0
Takuo Touma	Director & GM of Employment Transition Support Department	2.8yrs	no data	no data

8.0yrs

Average Tenure

52yo

Average Age

Experienced Management: 6556's management team is seasoned and experienced (8 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Makoto Ota	President & Representative Director	12.5yrs	no data	20% ¥ 6.0b
Hideyuki Nakazato	GM of Welfare Service Business Department & Director	8yrs	no data	0% ¥ 0
Takao Senga	Senior EVP	8yrs	no data	0% ¥ 0
Koichi Ito	Director & GM of Business Planning Department	5yrs	no data	0% ¥ 0
Takuo Touma	Director & GM of Employment Transition Support Department	2yrs	no data	no data
Yasutoshi Kita	Independent Outside Director	8yrs	no data	0% ¥ 0
Hiyoshi Sato	Outside Independent Director	3yrs	no data	0% ¥ 0
Shigenobu Kanba	External Independent Outside Director	5yrs	no data	no data
Eri Watanabe	Director	no data	no data	0% ¥ 0
Yumiko Noguchi	External Independent Outside Director	2yrs	no data	no data

5.0yrs

Average Tenure

50yo

Average Age

Experienced Board: 6556's board of directors are considered experienced (5 years average tenure).

Welbe Management

Management criteria checks 2/4

Key information

Recent management updates

Less than half of directors are independent

Welbe, Inc., Annual General Meeting, Jun 28, 2022

Less than half of directors are independent

Recent updates

Welbe, Inc. to Delist from Prime Section of Tokyo Stock Exchange, Effective June 11, 2024

Welbe, Inc. to Delist from Prime Section of Tokyo Stock Exchange, Effective June 11, 2024

Full year 2024 earnings released: EPS: JP¥44.12 (vs JP¥48.69 loss in FY 2023)

Welbe, Inc. to Report Fiscal Year 2024 Results on May 14, 2024

Why Investors Shouldn't Be Surprised By Welbe, Inc.'s (TSE:6556) 28% Share Price Surge

Third quarter 2024 earnings released: EPS: JP¥11.72 (vs JP¥2.90 in 3Q 2023)

New major risk - Revenue and earnings growth

Welbe, Inc. to Report Q3, 2024 Results on Feb 13, 2024

Investor sentiment improves as stock rises 16%

Second quarter 2024 earnings released: EPS: JP¥11.65 (vs JP¥14.77 in 2Q 2023)

New major risk - Share price stability

Now 22% undervalued

Welbe, Inc. to Report Q2, 2024 Results on Nov 13, 2023

Welbe, Inc. Provides Consolidated Financial Forecast for the First Half of 2024 and Fiscal Year Ending March 31, 2024

First quarter 2024 earnings released: EPS: JP¥8.06 (vs JP¥55.02 loss in 1Q 2023)

Now 20% undervalued after recent price drop

Welbe, Inc. to Report Q1, 2024 Results on Aug 10, 2023

Welbe, Inc Provides Dividend Guidance for the Second Quarter Ending September 30, 2023 and Year Ending March 31, 2024

Third quarter 2023 earnings released: EPS: JP¥2.90 (vs JP¥18.13 in 3Q 2022)

Welbe, Inc. to Report Q3, 2023 Results on Feb 13, 2023

Less than half of directors are independent

Second quarter 2023 earnings released: EPS: JP¥14.77 (vs JP¥16.36 in 2Q 2022)

WH LLC agreed to acquire Welbe Healthcare Inc from Welbe, Inc. (TSE:6556) for ¥ approximately 1.8 billion.

Welbe, Inc. to Report Q2, 2023 Results on Nov 11, 2022

Welbe, Inc. Provides Dividend Guidance for the Full Year Ending March 31, 2023

Welbe, Inc. (TSE:6556) announces an Equity Buyback for 1,550,000 shares, representing 5.38% for ¥1,000 million.

First quarter 2023 earnings released: JP¥55.02 loss per share (vs JP¥13.91 profit in 1Q 2022)

Welbe, Inc. Ordinary Shares to Be Deleted from OTC Equity

Consensus forecasts updated

Welbe, Inc., Annual General Meeting, Jun 28, 2022

Price target decreased to JP¥1,500

Less than half of directors are independent

Welbe, Inc. to Report Fiscal Year 2022 Results on May 13, 2022

Upcoming dividend of JP¥8.10 per share

Investor sentiment deteriorated over the past week

Welbe, Inc. Provides Earnings Guidance for the Year Ending March 31, 2022

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Price target decreased to JP¥1,950

Second quarter 2022 earnings released: EPS JP¥16.36 (vs JP¥11.95 in 2Q 2021)

Upcoming dividend of JP¥8.00 per share

Investor sentiment improved over the past week

Upcoming dividend of JP¥10.30 per share

Welbe, Inc. to Report Q3, 2021 Results on Feb 12, 2021

New 90-day low: JP¥1,464

Welbe, Inc. to Report Q2, 2021 Results on Nov 13, 2020

CEO

Tenure

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age